BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,149,305 | +80036.6% | 268,927 | -3.3% | 0.02% | -10.5% |
| Q2 2023 | $12,665 | +16.5% | 278,176 | +3.7% | 0.02% | +5.6% |
| Q1 2023 | $10,875 | -19.5% | 268,272 | +1.1% | 0.02% | -10.0% |
| Q4 2022 | $13,512 | -99.9% | 265,241 | -17.1% | 0.02% | -35.5% |
| Q3 2022 | $17,220,000 | +3.7% | 319,776 | +23.7% | 0.03% | 0.0% |
| Q2 2022 | $16,604,000 | -28.8% | 258,554 | -14.0% | 0.03% | -11.4% |
| Q1 2022 | $23,305,000 | +7.6% | 300,559 | +19.1% | 0.04% | +20.7% |
| Q4 2021 | $21,659,000 | +13.3% | 252,319 | +6.2% | 0.03% | -3.3% |
| Q3 2021 | $19,109,000 | +5.2% | 237,597 | +5.3% | 0.03% | +7.1% |
| Q2 2021 | $18,169,000 | -15.4% | 225,724 | -11.3% | 0.03% | -26.3% |
| Q1 2021 | $21,468,000 | -18.0% | 254,546 | -22.0% | 0.04% | -20.8% |
| Q4 2020 | $26,167,000 | +11.1% | 326,132 | +11.3% | 0.05% | -17.2% |
| Q3 2020 | $23,558,000 | -19.8% | 292,916 | -14.1% | 0.06% | -21.6% |
| Q2 2020 | $29,376,000 | -16.6% | 341,157 | -21.3% | 0.07% | -31.5% |
| Q1 2020 | $35,221,000 | -11.8% | 433,732 | -9.2% | 0.11% | +61.2% |
| Q4 2019 | $39,946,000 | +12.6% | 477,766 | +17.8% | 0.07% | -10.7% |
| Q3 2019 | $35,465,000 | -51.4% | 405,504 | -54.5% | 0.08% | +226.1% |
| Q2 2019 | $72,940,000 | +63.7% | 890,790 | +62.5% | 0.02% | -67.1% |
| Q1 2019 | $44,559,000 | +46.5% | 548,112 | +18.6% | 0.07% | +34.6% |
| Q4 2018 | $30,410,000 | +20.4% | 462,075 | +41.0% | 0.05% | +13.0% |
| Q3 2018 | $25,265,000 | +6.3% | 327,816 | +1.8% | 0.05% | -4.2% |
| Q2 2018 | $23,777,000 | +31.2% | 322,078 | +15.5% | 0.05% | +20.0% |
| Q1 2018 | $18,125,000 | +20.9% | 278,763 | +20.2% | 0.04% | -9.1% |
| Q4 2017 | $14,993,000 | +12.7% | 231,943 | +9.4% | 0.04% | +2.3% |
| Q3 2017 | $13,304,000 | +12.6% | 212,015 | +8.6% | 0.04% | +13.2% |
| Q2 2017 | $11,818,000 | +40.0% | 195,180 | +20.0% | 0.04% | +65.2% |
| Q1 2017 | $8,441,000 | +54.9% | 162,695 | +32.4% | 0.02% | +43.8% |
| Q4 2016 | $5,451,000 | +106.8% | 122,889 | +122.2% | 0.02% | +77.8% |
| Q3 2016 | $2,636,000 | +27.4% | 55,303 | +21.5% | 0.01% | 0.0% |
| Q2 2016 | $2,069,000 | +5.3% | 45,511 | -5.2% | 0.01% | -25.0% |
| Q1 2016 | $1,964,000 | -15.9% | 47,985 | -21.4% | 0.01% | -14.3% |
| Q4 2015 | $2,335,000 | +14.0% | 61,038 | -1.8% | 0.01% | +16.7% |
| Q3 2015 | $2,048,000 | +17.2% | 62,130 | +148.6% | 0.01% | +50.0% |
| Q2 2015 | $1,747,000 | -51.9% | 24,991 | -52.9% | 0.01% | -50.0% |
| Q1 2015 | $3,635,000 | -17.2% | 53,079 | -11.5% | 0.02% | -5.9% |
| Q4 2014 | $4,391,000 | +37.6% | 59,967 | +35.6% | 0.02% | +70.0% |
| Q2 2014 | $3,192,000 | -13.3% | 44,216 | -8.9% | 0.01% | -23.1% |
| Q1 2014 | $3,683,000 | +1508.3% | 48,551 | +1376.2% | 0.01% | +1200.0% |
| Q2 2013 | $229,000 | -4.2% | 3,289 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $239,000 | – | 3,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |